SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 96.0 | -2.2 | 1 | 3 | 83.0 | 0 | 0.0 |
- CAS
- 7782856
- UNII
- 70WT22SF4B
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Oral | Capsule | 500MG |
| An,infiltration | Injection | 0.02% |
| Auricular (otic) | Solution | 0.5% |
| Auricular (otic) | Suspension | |
| Im - Iv | Injection | 20% |
| Im - Iv | Powder | 27.93% |
| Im - Iv | Powder, For Injection Solution | 8% |
| Im - Iv | Solution, Injection | 0.57% |
| Im - Iv - Sc | Injection | |
| Im - Sc | Injection | 0.03% |
| Im - Sc | Powder, For Injection Solution | |
| Intra-Articular | Injectable | 3% |
| Intra-Articular | Injection | |
| Intra-Articular | Suspension | 0.35% |
| Intrabursal | Injection | |
| Intradermal | Injection | |
| Intralesional | Injection | |
| Intralesional | Injection, Sustained Action | |
| Intramuscular | Injectable | 0.3%W/W |
| Intramuscular | Injection | |
| Intramuscular | Injection, Sustained Action | 0.07% |
| Intramuscular | Powder, For Injection Solution | 0.54% |
| Intramuscular | Powder, For Injection Solution, Lyophilized | 0.09%W/V |
| Intramuscular | Powder, For Injection Solution, Lyophilized, With Additives | 0.37% |
| Intramuscular | Solution, Injection | |
| Intramuscular | Suspension | |
| Intrasynovial | Injection, Sustained Action | |
| Intravenous | Injection | 1.44% |
| Intravenous | Powder, For Injection Solution | 2.9% |
| Intravenous | Solution, Injection | 1.44% |
| Intravitreal | Injectable | 3% |
| Iv(infusion) | Injection | 1.23% |
| Iv(infusion) | Powder, For Injection Solution | 2% |
| Iv(infusion) | Powder, For Injection Solution, Lyophilized | 0.09%W/V |
| Nasal | Solution | 0.05% |
| Nasal | Solution, Spray | |
| Nasal | Spray, Metered | 0.49% |
| Nerve Block | Injection | 0.02% |
| Ophthalmic | Drops | 0.36% |
| Ophthalmic | Solution | 2.15% |
| Ophthalmic | Solution, Drops | 2.5% |
| Ophthalmic | Solution/drops | 0.55% |
| Ophthalmic | Suspension | 0.87% |
| Ophthalmic | Suspension, Drops | 0.43% |
| Oral | Capsule, Sustained Action | 92MG |
| Oral | Drops | |
| Oral | Solution | 1.41% |
| Oral | Suspension | 1.25% |
| Oral | Syrup | 0.02% |
| Oral | Tablet | 80MG |
| Oral | Tablet, Coated | 0.22MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 16.24MG |
| Oral | Tablet, Sustained Action | 70MG |
| Oral | Tablet, Sustained Action, Film Coated | 105MG |
| Oral-20 | Tablet | 0.001MG |
| Soft Tissue | Injection | |
| Soft Tissue | Injection, Sustained Action | |
| Subcutaneous | Injectable | 0.19% |
| Subcutaneous | Injection | 0.38% |
| Subcutaneous | Powder, For Injection Solution | 0.54% |
| Subcutaneous | Powder, For Injection Solution, Lyophilized | 0.34% |
| Subcutaneous | Solution, Injection | 0.09% |
| Subcutaneous | Suspension | 0.38% |
| Subcutaneous | Suspension, Injection | 0.38% |
| Topical | Emulsion, Cream | 0.34% |
| Topical | Lotion | 1.59% |
| Topical | Ointment | 0.15% |
| Topical | Solution | 49.78% |
| Topical | Sponge | |
| Urethral | Injection | 2% |